Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: ASH001
MIFTS: 33

Asherman's Syndrome

Categories: Rare diseases, Reproductive diseases
Genes Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Asherman's Syndrome

About this section

MalaCards integrated aliases for Asherman's Syndrome:

Name: Asherman's Syndrome 53
Asherman Syndrome 53 59 72
Intrauterine Adhesions 59 72
Intrauterine Synechiae 53 59
Adhesions of Uterus 72
Uterine Synechiae 53

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Reproductive diseases
See all MalaCards categories (disease lists)
ICD10: 34
Orphanet: 59  
Rare gynaecological and obstetric diseases


External Ids:

ICD10 via Orphanet 34 N85.6
UMLS via Orphanet 73 C0156372 C0241593 C1704274
Orphanet 59 ORPHA137686
UMLS 72 C0156372 C0241593 C1704274
Sources

Summaries for Asherman's Syndrome

About this section
MalaCards based summary : Asherman's Syndrome, also known as asherman syndrome, is related to amenorrhea and infertility. An important gene associated with Asherman's Syndrome is NFKB1 (Nuclear Factor Kappa B Subunit 1). The drugs Dimenhydrinate and Estradiol have been mentioned in the context of this disorder. Affiliated tissues include uterus, bone and placenta, and related phenotypes are secondary amenorrhea and episodic abdominal pain

Sources

Related Diseases for Asherman's Syndrome

About this section

Diseases related to Asherman's Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 50)
# Related Disease Score Top Affiliating Genes
1 amenorrhea 10.7
2 infertility 10.7
3 placenta accreta 10.6
4 adhesions of uterus 10.4
5 endometriosis 10.3
6 cervical incompetence 10.3
7 preterm premature rupture of the membranes 10.3
8 ectopic pregnancy 10.2
9 endometritis 10.2
10 placenta praevia 10.2
11 placenta disease 10.2
12 hypogonadotropism 10.2
13 myoma 10.1
14 endometrial cancer 10.1
15 schistosoma mansoni infection, susceptibility/ 10.1
16 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.1
17 pre-eclampsia 10.1
18 schistosomiasis 10.1
19 hemometra 10.1
20 uterine inversion 10.1
21 placental abruption 10.0
22 septate uterus 10.0
23 scoliosis 10.0
24 thrombosis 10.0
25 hypogonadotropic hypogonadism 10.0
26 hypogonadism 10.0
27 thrombophilia 10.0
28 aneurysm 10.0
29 bicornuate uterus 10.0
30 endometrial adenocarcinoma 10.0
31 amniotic band syndrome 10.0
32 leukemia, acute lymphoblastic 3 10.0
33 48,xyyy 10.0
34 fibrosis of extraocular muscles, congenital, 1 9.9
35 uterine anomalies 9.9
36 leiomyoma 9.9
37 myofibroma 9.9
38 ocular motor apraxia 9.7
39 enhanced s-cone syndrome 9.7
40 premature ovarian failure 1 9.7
41 adenomyosis 9.7
42 endometrial hyperplasia 9.7
43 vaginal cancer 9.7
44 hyperglycemia 9.7
45 keratinizing squamous cell carcinoma 9.7
46 severe combined immunodeficiency 9.7
47 combined t cell and b cell immunodeficiency 9.7
48 47,xyy 9.7
49 rapidly involuting congenital hemangioma 9.7
50 overgrowth syndrome 9.7

Comorbidity relations with Asherman's Syndrome via Phenotypic Disease Network (PDN):


Myofibroma

Graphical network of the top 20 diseases related to Asherman's Syndrome:



Diseases related to Asherman's Syndrome
Sources

Symptoms & Phenotypes for Asherman's Syndrome

About this section

Human phenotypes related to Asherman's Syndrome:

59 (show all 11)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 secondary amenorrhea 59 Occasional (29-5%)
2 episodic abdominal pain 59 Occasional (29-5%)
3 abnormality of the menstrual cycle 59 Frequent (79-30%)
4 infertility 59 Occasional (29-5%)
5 metrorrhagia 59 Occasional (29-5%)
6 spontaneous abortion 59 Occasional (29-5%)
7 dysmenorrhea 59 Occasional (29-5%)
8 decreased fertility in females 59 Frequent (79-30%)
9 oligomenorrhea 59 Frequent (79-30%)
10 chronic infection 59 Very rare (<4-1%)
11 abnormality of the placenta 59 Very rare (<4-1%)
Sources

Drugs & Therapeutics for Asherman's Syndrome

About this section

Drugs for Asherman's Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 54)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dimenhydrinate Approved Phase 4 523-87-5 441281
2
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
3
Polyestradiol phosphate Approved Phase 4 28014-46-2
4 Carboxymethylcellulose Sodium Phase 4
5 Estrogens Phase 4
6 Contraceptive Agents Phase 4
7 Hormones Phase 4
8 Estradiol 17 beta-cypionate Phase 4
9 Hormone Antagonists Phase 4
10 Progestins Phase 4
11 Estradiol 3-benzoate Phase 4
12 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
13
Misoprostol Approved Phase 3 59122-46-2 5282381
14
Mifepristone Approved, Investigational Phase 3 84371-65-3 55245
15
Tacrolimus Approved, Investigational Phase 3 104987-11-3 445643 439492 6473866
16 Contraceptives, Oral Phase 3
17 Antacids Phase 3
18 Contraceptives, Postcoital Phase 3
19 Gastrointestinal Agents Phase 3
20 Luteolytic Agents Phase 3
21 Oxytocics Phase 3
22 Anti-Ulcer Agents Phase 3
23 Immunologic Factors Phase 3
24 Immunosuppressive Agents Phase 3
25 Calcineurin Inhibitors Phase 3
26
Sargramostim Approved, Investigational Phase 1, Phase 2 83869-56-1, 123774-72-1
27
Lenograstim Approved, Investigational Phase 1, Phase 2 135968-09-1
28 Anti-Bacterial Agents Phase 2
29 Antibiotics, Antitubercular Phase 2
30 Anesthetics Phase 2
31 Adjuvants, Immunologic Phase 1, Phase 2
32
Copper Approved, Investigational 7440-50-8 27099
33
Ethanol Approved Early Phase 1 64-17-5 702
34
Hyaluronic acid Approved, Vet_approved 9004-61-9 53477741
35
Zaleplon Approved, Illicit, Investigational 151319-34-5 5719
36
Iodine Approved, Investigational 7553-56-2 807
37
Povidone Approved 9003-39-8
38
carbamide peroxide Approved 124-43-6
39
Progesterone Approved, Vet_approved 57-83-0 5994
40
Medroxyprogesterone acetate Approved, Investigational 71-58-9
41
Aspirin Approved, Vet_approved 50-78-2 2244
42
Povidone-iodine Approved 25655-41-8
43
Lidocaine Approved, Vet_approved 137-58-6 3676
44
Prednisone Approved, Vet_approved 53-03-2 5865
45
Mycophenolic acid Approved 24280-93-1 446541
46
Azathioprine Approved 446-86-6 2265
47
Imidacloprid Vet_approved 105827-78-9 86418
48 Protective Agents
49 Viscosupplements
50 Calamus

Interventional clinical trials:

(show top 50) (show all 62)
# Name Status NCT ID Phase Drugs
1 The Role of Seprafilm Bioresorbable Slurry in the Prevention of Intrauterine Synechiae in Patients Undergoing Hysteroscopic Myomectomy Unknown status NCT01632202 Phase 4
2 Effectiveness of Self-cross-linked Hyaluronic Acid Gel in the Prevention of Intrauterine Adhesions After Second Trimester Abortion Unknown status NCT02868437 Phase 4
3 Clinical Study of the Treatment of Infertility Caused by Severe Intrauterine Adhesions by Collagen Scaffold Loaded With Autologous Bone Marrow Stem Cells Unknown status NCT02204358 Phase 4
4 New Therapeutic Approaches to Treat Asherman's Syndrome and Endometrial Atrophy Based in BM Stem Cells Autologous Transplantation Completed NCT02144987 Phase 4
5 The Effect of Estrogen in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis Enrolling by invitation NCT03620929 Phase 4 Estradiol Valerate
6 Cervical Preparation for Surgical Abortion at 12-14 Weeks: a Prospective, Randomized, Evaluator-blinded, Multicenter, Controlled Comparison Between Mifepristone, Misoprostol and Their Combination Unknown status NCT01795599 Phase 3 Mifegyne ®;Gymiso®
7 Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study Recruiting NCT03277430 Phase 3 Tacrolimus
8 Non-stick Gel Applicated After Scraping Surgery for Natural Miscarriage and Uterine Synechiae Prevention Active, not recruiting NCT02248376 Phase 3 Gel
9 A Prospective, Randomized, Controlled Trial Comparing 2 Different Doses of Estrogen Therapy After Hysteroscopic Adhesiolysis as an Adjuvant to Prevent Recurrence of Intrauterine Adhesions Completed NCT02726971 Phase 1, Phase 2 Femoston
10 Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair: a Prospective Randomised Pilot Study Completed NCT02825849 Phase 2
11 A Multi-center, Randomized, Single-blind, Controlled Clinical Trial of Treatment of Severe Asherman Syndrome by Collagen Scaffold Loaded With Autologous Bone Marrow Mononuclear Cells Recruiting NCT02680366 Phase 2
12 Intrauterine Infusion of Autologous Platelet-Rich Plasma (PRP) in Women With Thin Endometrium Undergoing Embryo-transfer. Recruiting NCT03067623 Phase 2 PRP
13 Open Randomized Trial of Clinical Efficiency and Safety of Cell Product of Autologous Bone Marrow-derived Mesenchymal Stem Cells for Reparative Treatment of Destructively Changed Endometrium in Patients With Repeated IVF Failures Active, not recruiting NCT03166189 Phase 2
14 G-CSF and Endometrial Growth, Embryo Implantation and Pregnancy Following FET or Donor ET Terminated NCT01202643 Phase 1, Phase 2 G-CSF;Saline
15 Phase I Study of Role of Stem Cells in Improving Implantation Rates in ICSI Patients Unknown status NCT01649752 Phase 1
16 Cesarean Myomectomy : Safety and Risk of Intrauterine Synechiae Completed NCT03095014 Phase 1
17 Safety and Therapeutic Effect of Human Amniotic Epithelial Cells in Severe Refractory Asherman's Syndrome Not yet recruiting NCT03223454 Phase 1
18 A Randomized Clinical Trial to Assess the Efficacy of Intrauterine Balloon Compared to Intrauterine Contraceptive Device in the Therapy for Uterine Adhesion After Hysteroscopic Adhesiolysis Unknown status NCT02867202
19 Amnion Graft for Preventing Intrauterine Adhesions Following Hysteroscopic Surgery Unknown status NCT02132104 Femoston
20 Use Of Hyaluronic Acid Gel To Prevent Intrauterine Adhesions In Hysteroscopic Surgery Unknown status NCT01464528 Early Phase 1 Hyaluronan
21 The Efficacy of Intrauterine Balloon Dilatation Therapy in the Prevention of Adhesion Reformation Following Hysteroscopic Adhesiolysis Unknown status NCT03131596
22 The Efficacy and Safety of the Dried Biological Amnion Graft Following Hysteroscopic Lysis for the Prevention of Postoperative Adhesions in Patients With Intrauterine Adhesions Unknown status NCT02496052 estradiol valerate tablets+dydrogesterone Tablets
23 Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel Unknown status NCT02404454
24 Randomized, Controlled Trial Comparing Immediate and Delayed Intrauterine Balloon Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis Unknown status NCT03171454
25 Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery - a Prospective Double Blind Randomized Study Unknown status NCT01637974 INTERCOAT administration
26 The Efficacy of Intrauterine Balloon Dilatation Therapy in the Prevention of Adhesion Formation After Hysteroscopicremovalof Multiple Fibroids Unknown status NCT03169478
27 Description of the Uterine Cavity in Patients With Recurrent Miscarriages Unknown status NCT02746588
28 The Value of Diagnostic Hysterolaparoscopy in Infertile Patients With Normal Hysterosalpingography Unknown status NCT03106012
29 Intercoat (Oxiplex/AP Gel) for Preventing Intrauterine Adhesions Following Operative Hysteroscopy for Suspected Retained Products of Conception - a Prospective Randomized Pilot Study Completed NCT01377779 Oxiplex/AP gel;Normal Saline
30 Reproductive Outcome Affected by Two Adjunctive Treatments in Patients With Infertility Due to Severe Intrauterine Adhesions. Completed NCT02708277
31 Prevalence of Chronic Endometritis in Severe Intrauterine Adhesions and Role of Chronic Endometritis in Postoperative Recurrence of Severe Intrauterine Completed NCT02744807
32 The Value of Using Platelet Rich Plasma After Hysteroscopic Lysis of Severe Intrauterine Adhesions (A Randomized Controlled Trial) Completed NCT03541746
33 Impact of Mindfulness Based Stress Reduction on Anxiety, Depression and Quality of Life in Women With Intrauterine Adhesion:a Randomized Controlled Trial. Completed NCT02746679
34 Autocrosslinked Hyaluronic Acid Gel in Prevention of Intrauterine Adhesions After Bipolar Radiofrequency Endometrial Ablation: a Randomised, Controlled and Double Blind Study Completed NCT01829451
35 Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids Completed NCT02844920
36 Clinical Study of the Treatment of Infertility Caused by Recurrent Intrauterine Adhesions by Collagen Scaffold Loaded With Umbilical Cord -Derived Mesenchymal Stem Cells (UC-MSCs) Completed NCT02313415
37 The Efficacy of A New Crosslinked Hyaluronan Gel in the Prevention of Postoperative Intrauterine Adhesion After Dilatation and Curettage in Women With Delayed Miscarriage: A Prospective, Randomized, Controlled Trial Completed NCT03353909
38 A Post-Market Clinical Follow-up Study to Investigate the Usability of the CollaGUARD Adhesion Barrier Following Hysteroscopic Adhesiolysis Completed NCT02348541 Early Phase 1
39 Prevention of Postsurgical Uterine Synechia With HyalobarrierR Gel Endo in Hysteroscopic Myomectomy : a Prospective Multicenter Study Completed NCT01412489
40 Magnetic Resonance Imaging Hysterosalpingography Versus Radiographic Hysterosalpingography in Female Infertility Completed NCT02108665
41 Sonohysterography and 3D Ultrasonography Versus Diagnostic Hysteroscopy in Assessment of Uterine Factor in Cases of Female Infertility Completed NCT02399501
42 Randomized, Controlled Trial to Assess the Efficacy of Disposable Balloon Uterine Stent Combined With Estrogen or Dried Biological Amnion Graft for the Therapy of Uterine Adhesion Recruiting NCT03346317 estradiol valerate tablets+dydrogesterone tablets
43 Randomized, Controlled Trial to Assess the Efficacy of Estrogen Therapy Combined With Disposable Balloon Uterine Stent and Dried Biological Amnion Graft in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis Recruiting NCT03351205 estradiol valerate tablets+dydrogesterone tablets
44 Randomized, Controlled Trial to Assess the Efficacy of Disposable Balloon Uterine Stent and Foley Catheter in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis Recruiting NCT03330873
45 Randomized, Controlled Trial to Assess the Efficacy of Disposable Balloon Uterine Stent Combined With Estrogen or Dried Biological Amnion Graft in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis Recruiting NCT03329898 estradiol valerate tablets;dydrogesterone Tablets
46 Biomedical Study of Toxicity, Biodistribution, Expression and Cellular Characterization of Autologous CD133+ Stem Cells From Donors of Hematopoietic Progenitors (IGX1) in Murine Model With Asherman-induced Syndrome. Recruiting NCT03665649
47 Endometrial Reconstruction by Human Regenerative Factors Derived From Platelet-Rich Plasma in Mice Models Recruiting NCT03249415
48 Treatment of Intrauterine Adhesions and Its Distribution of Genital Tract Flora Recruiting NCT03731689 Intrauterine lavage therapy;Intrauterine gel-injection therapy
49 The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis Recruiting NCT02855632 G-CSF;Normal saline;hormone therapy
50 Effect of Pelvic Floor Muscle Electrophysiologic Therapy on Enhanced Recovery After Gynecologic Surgery Recruiting NCT03524807

Search NIH Clinical Center for Asherman's Syndrome

Sources

Genetic Tests for Asherman's Syndrome

About this section
Sources

Anatomical Context for Asherman's Syndrome

About this section

MalaCards organs/tissues related to Asherman's Syndrome:

41
Uterus, Bone, Placenta, Bone Marrow, Cervix
Sources

Publications for Asherman's Syndrome

About this section

Articles related to Asherman's Syndrome:

(show top 50) (show all 278)
# Title Authors PMID Year
1
A cohort study comparing 4 mg and 10 mg daily doses of postoperative oestradiol therapy to prevent adhesion reformation after hysteroscopic adhesiolysis. 38
29504823 2019
2
Human amniotic epithelial cells improve fertility in an intrauterine adhesion mouse model. 38
31412924 2019
3
Myometrial cells stimulate self-renewal of endometrial mesenchymal stem-like cells through WNT5A/β-catenin signaling. 38
31414525 2019
4
Hyaluronic Acid Hydrogel Integrated with Mesenchymal Stem Cell-Secretome to Treat Endometrial Injury in a Rat Model of Asherman's Syndrome. 38
31148407 2019
5
A cohort study comparing the severity and outcome of intrauterine adhesiolysis for Asherman syndrome after first- or second-trimester termination of pregnancy. 38
31082744 2019
6
Assisted reproductive technology strategies in uterus transplantation. 38
31277762 2019
7
One-Year Follow-Up of Women with Severe Acute Maternal Morbidity (SAMM): A Cohort Study. 38
31178635 2019
8
A mechanisms of endometrial fibrosis and the potential application of stem cell therapy. 38
31421695 2019
9
Cell and biomaterial-based approaches to uterus regeneration. 38
31198582 2019
10
Cellular therapies for the endometrium: An update. 38
30815850 2019
11
Single cell-derived clonally expanded mesenchymal progenitor cells from somatic cell nuclear transfer-derived pluripotent stem cells ameliorate the endometrial function in the uterus of a murine model with Asherman's syndrome. 38
30896075 2019
12
A Novel Ultrasound-Guided Technique for Hysteroscopic Adhesiolysis in High-Risk Patients. 38
30208242 2019
13
Bone Marrow Mesenchymal Stem Cells (BMSCs) Restore Functional Endometrium in the Rat Model for Severe Asherman Syndrome. 38
30458678 2019
14
The efficacy of Ankaferd Blood Stopper® in an experimental Asherman syndrome model created in rats. 38
31019834 2019
15
Endometrial Regeneration in Asherman's Syndrome: Clinical and Translational evidence of Stem Cell Therapies. 38
30760192 2019
16
Asherman's syndrome: current perspectives on diagnosis and management. 38
30936754 2019
17
Case report of pelvic tuberculosis resulting in Asherman's syndrome and infertility. 38
31388435 2019
18
The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine. 38
30606242 2019
19
Reproductive outcomes after surgical treatment of asherman syndrome: A systematic review. 38
30713131 2019
20
A multidisciplinary approach to pregnancy loss: the pregnancy loss prevention center. 38
29858908 2018
21
Detection of Asherman's syndrome after conservative management of placenta accreta: a case report. 38
30454053 2018
22
The CXL12/CXCR4/CXCR7 axis in female reproductive tract disease: Review. 38
30106199 2018
23
Uterine stem cells: from basic research to advanced cell therapies. 38
30239705 2018
24
Infertility after abdominal trachelectomy. 38
30063086 2018
25
Meta-analysis of the use of amniotic membrane to prevent recurrence of intrauterine adhesion after hysteroscopic adhesiolysis. 38
30073656 2018
26
Live birth rate and obstetric complications following the hysteroscopic management of intrauterine adhesions including Asherman syndrome. 38
30239778 2018
27
[Asherman's syndrome : management after curettage following a postnatal placental retention and literature review]. 38
30335256 2018
28
The birth weight in pregnant women with Asherman syndrome compared to normal intrauterine cavity: A case-control study. 38
30095642 2018
29
The association between menstrual cycle pattern and hysteroscopic march classification with endometrial thickness among infertile women with Asherman syndrome. 38
29979403 2018
30
Therapeutic strategies involving uterine stem cells in reproductive medicine. 38
29652725 2018
31
Stem cell therapy in Asherman syndrome and thin endometrium: Stem cell- based therapy. 38
29571018 2018
32
Laparoscopic-Assisted Uterus Retrieval From Live Organ Donors for Uterine Transplant. 38
29133152 2018
33
Platelet-rich plasma in the management of Asherman syndrome: case report. 38
29455274 2018
34
Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report. 38
28939480 2018
35
Hysteroscopic Management of Asherman's Syndrome. 38
29024798 2018
36
Human mesenchymal stem cells in spheroids improve fertility in model animals with damaged endometrium. 38
29482664 2018
37
Systemic administration of bone marrow-derived cells leads to better uterine engraftment than use of uterine-derived cells or local injection. 38
28782281 2018
38
Clinical and Reproductive Outcomes Following Hysteroscopic Adhesiolysis for Asherman Syndrome in an Asian Population. 38
29493709 2018
39
The effect of endometrial thickness on pregnancy outcome in patients with Asherman's syndrome post-hysteroscopic adhesiolysis. 38
29483785 2018
40
Accuracy of Two-Dimensional Transvaginal Sonography and Office Hysteroscopy for Detection of Uterine Abnormalities in Patients with Repeated Implantation Failures or Recurrent Pregnancy Loss. 38
29043704 2018
41
Placenta Accreta following Hysteroscopic Lysis of Adhesions Caused by Asherman's Syndrome: A Case Report and Literature Review. 38
29955406 2018
42
Bone Marrow Stem Cells Do Not Contribute to Endometrial Cell Lineages in Chimeric Mouse Models. 38
28913973 2018
43
Advanced Role of Hippo Signaling in Endometrial Fibrosis: Implications for Intrauterine Adhesion. 38
29133764 2017
44
Replacing single frozen-thawed euploid embryos in a natural cycle in ovulatory women may increase live birth rates compared to medicated cycles in anovulatory women. 38
28647784 2017
45
A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options. 38
28582327 2017
46
Anti-Mullerian hormone as a parameter for endometrial trauma in Asherman syndrome: A retrospective data analysis. 38
28400095 2017
47
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset. 38
28389908 2017
48
Transplantation of collagen scaffold with autologous bone marrow mononuclear cells promotes functional endometrium reconstruction via downregulating ΔNp63 expression in Asherman's syndrome. 38
27921235 2017
49
CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman's Syndrome. 38
28345002 2017
50
Gynecologic Surgery: Preoperative Assessment With Ultrasound. 38
28059844 2017
Sources

Variations for Asherman's Syndrome

About this section
Sources

Expression for Asherman's Syndrome

About this section
Search GEO for disease gene expression data for Asherman's Syndrome.
Sources

Pathways for Asherman's Syndrome

About this section
Sources

GO Terms for Asherman's Syndrome

About this section
Sources

Sources for Asherman's Syndrome

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....